PMID- 12470870 OWN - NLM STAT- MEDLINE DCOM- 20030327 LR - 20220330 IS - 0006-8993 (Print) IS - 0006-8993 (Linking) VI - 958 IP - 2 DP - 2002 Dec 27 TI - Involvement of a spinal brain-derived neurotrophic factor/full-length TrkB pathway in the development of nerve injury-induced thermal hyperalgesia in mice. PG - 338-46 AB - Partial sciatic nerve ligation in mice caused a marked and persistent decrease in the latency of paw withdrawal from a thermal stimulus only on the ipsilateral side. This thermal hyperalgesia was abolished by repeated intrathecal pretreatment with a specific antibody to brain-derived neurotrophic factor (BDNF), but not neurotrophin-4, just before and after the nerve ligation. These results provide direct evidence that BDNF within the spinal cord may contribute to the development of thermal hyperalgesia caused by nerve injury in mice. We previously reported that protein level of full-length TrkB, which contains the cytoplasmic protein tyrosine kinase domain, were clearly increased on the ipsilateral side of spinal cord membranes obtained from sciatic nerve-ligated mice. In the present study, we further demonstrated that the increased in the protein level of full-length TrkB is completely reversed by concomitant intrathecal injection of BDNF antibody. Furthermore, thermal hyperalgesia induced by nerve ligation was completely suppressed by repeated intrathecal injection of a specific antibody to full-length TrkB and an inhibitor of the protein tyrosine kinase activity for the neurotrophin receptor, K-252a. However, repeated intrathecal injection of a specific antibody to truncated TrkB, which lacks the cytoplasmic protein tyrosine kinase domain, failed to reverse thermal hyperalgesia observed in nerve-ligated mice. These findings suggest the possibility that the binding of BDNF to full-length TrkB and subsequent its activation may play a critical role in the development of neuropathic pain-like thermal hyperalgesia induced by nerve injury in mice. CI - Copyright 2002 Elsevier Science B.V. FAU - Yajima, Yoshinori AU - Yajima Y AD - Department of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan. FAU - Narita, Minoru AU - Narita M FAU - Narita, Michiko AU - Narita M FAU - Matsumoto, Nozomi AU - Matsumoto N FAU - Suzuki, Tsutomu AU - Suzuki T LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - Brain Res JT - Brain research JID - 0045503 RN - 0 (Brain-Derived Neurotrophic Factor) RN - EC 2.7.10.1 (Receptor, trkB) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/*antagonists & inhibitors/*physiology MH - Hot Temperature/adverse effects MH - Hyperalgesia/drug therapy/*metabolism MH - Male MH - Mice MH - Mice, Inbred ICR MH - Pain Measurement/drug effects/methods MH - Receptor, trkB/*antagonists & inhibitors/*physiology MH - Sciatic Neuropathy/drug therapy/*metabolism MH - Signal Transduction/drug effects/*physiology MH - Spinal Cord/drug effects/metabolism EDAT- 2002/12/10 04:00 MHDA- 2003/03/28 05:00 CRDT- 2002/12/10 04:00 PHST- 2002/12/10 04:00 [pubmed] PHST- 2003/03/28 05:00 [medline] PHST- 2002/12/10 04:00 [entrez] AID - S0006899302036661 [pii] AID - 10.1016/s0006-8993(02)03666-1 [doi] PST - ppublish SO - Brain Res. 2002 Dec 27;958(2):338-46. doi: 10.1016/s0006-8993(02)03666-1.